Left Ventricular Ejection Fraction Association with Acute Ischemic Stroke Outcomes in Patients Undergoing Thrombolysis
Authors:
- Ryan C. H. CheeRCRyan C. H. Chee
- Norman H. LinNLNorman H. Lin
- Jamie S. Y. HoJHJamie S. Y. Ho
- Aloysius S. T. LeowALAloysius S. T. Leow
- Tony Y. W. LiTLTony Y. W. Li
- Edward C. Y. LeeELEdward C. Y. Lee
- Mark Y. ChanMCMark Y. Chan
- William K. F. KongWKWilliam K. F. Kong
- Tiong-Cheng YeoTYTiong-Cheng Yeo
- Ping ChaiPCPing Chai
- James W. L. YipJYJames W. L. Yip
- Kian-Keong PohKPKian-Keong Poh
Open Access
- 25 May 2023
- journal article
- research article
- Published by MDPI AG in Journal of Cardiovascular Development and Disease
- Vol. 10 (6) , 231
Abstract
(1) Background: Little is known about how left ventricular systolic dysfunction (LVSD) affects functional and clinical outcomes in acute ischemic stroke (AIS) patients undergoing thrombolysis; (2) Methods: A retrospective observational study conducted between 2006 and 2018 included 937 consecutive AIS patients undergoing thrombolysis. LVSD was defined as left ventricular ejection fraction (LVEF) < 50%. Univariate and multivariate binary logistic regression analysis was performed for demographic characteristics. Ordinal shift regression was used for functional modified Rankin Scale (mRS) outcome at 3 months. Survival analysis of mortality, heart failure (HF) admission, myocardial infarction (MI) and stroke/transient ischemic attack (TIA) was evaluated with a Cox-proportional hazards model; (3) Results: LVSD patients in comparison with LVEF ≥ 50% patients accounted for 190 and 747 patients, respectively. LVSD patients had more comorbidities including diabetes mellitus (100 (52.6%) vs. 280 (37.5%), p < 0.001), atrial fibrillation (69 (36.3%) vs. 212 (28.4%), p = 0.033), ischemic heart disease (130 (68.4%) vs. 145 (19.4%), p < 0.001) and HF (150 (78.9%) vs. 46 (6.2%), p < 0.001). LVSD was associated with worse functional mRS outcomes at 3 months (adjusted OR 1.41, 95% CI 1.03–1.92, p = 0.030). Survival analysis identified LVSD to significantly predict all-cause mortality (adjusted HR [aHR] 3.38, 95% CI 1.74–6.54, p < 0.001), subsequent HF admission (aHR 4.23, 95% CI 2.17–8.26, p < 0.001) and MI (aHR 2.49, 95% CI 1.44–4.32, p = 0.001). LVSD did not predict recurrent stroke/TIA (aHR 1.15, 95% CI 0.77–1.72, p = 0.496); (4) Conclusions: LVSD in AIS patients undergoing thrombolysis was associated with increased all-cause mortality, subsequent HF admission, subsequent MI and poorer functional outcomes, highlighting a need to optimize LVEF.Keywords
Funding Information
- National University of Singapore, Yong Loo Lin School of Medicine’s Junior Academic Fellowship Scheme
This publication has 68 references indexed in Scilit:
- EPITHETStroke, 2011
- National Institutes of Health Stroke Scale Certification Is Reliable Across Multiple VenuesStroke, 2009
- Predictors of Early Cardiac Morbidity and Mortality After Ischemic StrokeStroke, 2007
- Outcomes Validity and Reliability of the Modified Rankin Scale: Implications for Stroke Clinical TrialsStroke, 2007
- Left Ventricular Systolic Dysfunction and the Risk of Ischemic Stroke in a Multiethnic PopulationStroke, 2006
- Contribution of Atrial Fibrillation to Incidence and Outcome of Ischemic StrokeStroke, 2005
- ATLANTIS TrialStroke, 2002
- Atrial Fibrillation and StrokeStroke, 1997
- Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.Stroke, 1993
- Ischemic cardiomyopathy: The myopathy of coronary artery diseaseThe American Journal of Cardiology, 1974